Table 1.
Clinical information of outpatients participated in this study
| Characteristics | 2013 (n = 84) | 2014 (n = 102) | 2015 (n = 223) | 2016 (n = 203) | 2017 (n = 192) | Total (n = 804) |
|---|---|---|---|---|---|---|
| Gender, male n, (%) | 55 (65.5) | 70 (68.6) | 128 (57.4) | 129 (63.5) | 119 (62.0) | 501 (62.3) |
| Age (yr), Median, (IQR) | 0.50 (0.25, 0.73) | 0.50 (0.25, 1.00) | 0.75 (0.42, 1.25) | 0.75 (0.33, 1.25) | 0.79 (0.47, 1.00) | 0.67 (0.38, 1.00) |
| Age (yr) n, (%) | ||||||
| < 6 months (ms) | 40 (47.6) | 36 (35.3) | 70 (31.4) | 65 (32.0) | 48 (25.0) | 259 (32.2) |
| 6 ms~ | 32 (38.1) | 40 (39.2) | 67 (30.0) | 67 (33.0) | 60 (31.3) | 266 (33.1) |
| 1 yr~ | 6 (7.1) | 16 (15.7) | 43 (19.3) | 42 (20.7) | 55 (28.6) | 162 (20.1) |
| 2 yr~ | 6 (7.1) | 10 (9.8) | 43 (19.3) | 29 (14.3) | 29 (15.1) | 117 (14.6) |
| Occupation, Scattered children | 81 (96.4) | 101 (99.0) | 216 (96.9) | 193 (95.1) | 186 (96.9) | 777 (96.6) |
| Fever, > 38.5 °C | 17 (20.2) | 24 (23.5) | 66 (29.6) | 44 (21.7) | 65 (33.9) | 216 (26.9) |
| C. difficile isolates n, (%) | 11 (13.1) | 35 (34.3) | 60 (26.9) | 36 (17.7) | 44 (22.9) | 186 (23.1) |
| Only toxigenic C. difficile, CA-CDI | 10 (11.9) | 23 (22.5) | 40 (17.9) | 26 (12.8) | 16 (8.3) | 115 (14.3) |
| Co-infections | 1 (1.2) | 11 (10.8) | 19 (8.5) | 10 (4.9) | 28 (14.6) | 69 (8.6) |
| Total viral infections | 4 (4.8) | 23 (22.5) | 88 (39.5) | 63 (31.0) | 116 (60.4) | 294 (36.6) |
| Rotavirus group Aa | 2 (2.4) | 0 | 44 (19.7) | 30 (14.8) | 47 (24.5) | 123 (15.3) |
| Norovirus GI & GIIb | 1 (1.2) | 20 (19.6) | 19 (8.5) | 26 (12.8) | 32 (16.7) | 98 (12.2) |
| Astrovirus | 1 (1.2) | 0 | 3 (1.3) | 0 | 3 (1.6) | 7 (0.9) |
| Sapovirus | 0 | 1 (1.0) | 9 (4.0) | 3 (1.5) | 3 (1.6) | 16 (2.0) |
| Adenovirus | 0 | 2 (2.0) | 4 (1.8) | 3 (1.5) | 1 (0.5) | 10 (1.2) |
| Multiple viruses | 0 | 0 | 9 (4.0) | 1 (0.5) | 30 (15.6) | 40 (5.0) |
a: No case was positive for Rotavirus group B;
b: Three cases were positive for Norovirus GI type, one in 2013, two in 2017 including one co-infected with Rotavirus group A